News
News

The latest updates from AFAR.

Grantees in the News: Jorge Ivan Castillo-Quan and Linda Partridge on triple drug combo and longevity of fruit flies PNAS

Oct 7
2019

Grantees in the News: Jorge Ivan Castillo-Quan and Linda Partridge on triple drug combo and longevity of fruit flies PNAS View MoreBACK

On September 30, 2019, Proceedings of the National Academy of Sciences of the United States of America (PNAS) published research by AFAR experts Jorge Ivan Castillo-Quan, PhD, and  Linda Partridge, DPhil, which found that a triple drug combination, including Rapamycin, extended the lifespan of fruit flies by 48 percent.

Dr. Castillo-Quan is a 2018 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research recipient, and a Research Fellow in Medicine at Harvard Catalyst.

Dr. Partridge is a 2010 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient. She is also the Managing Director of the Max Planck Institute for Biology of Ageing in Cologne, Germany, and a Professional Research Fellow of Genetics, Evolution, and Environment at the University College of London.

The research was partially funded by Dr. Castillo-Quan’s 2018 grant.

Read the research, “A triple drug combination targeting components of the nutrient-sensing network maximizes longevity,” here.

Read a press release highlighting the research here.





View MoreBACK TO TOP